146 related articles for article (PubMed ID: 24632442)
21. S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
Leri M; Rebuzzini P; Caselli A; Luti S; Natalello A; Giorgetti S; Marchese L; Garagna S; Stefani M; Paoli P; Bucciantini M
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129453. PubMed ID: 31676294
[TBL] [Abstract][Full Text] [Related]
22. The pathway by which the tetrameric protein transthyretin dissociates.
Foss TR; Wiseman RL; Kelly JW
Biochemistry; 2005 Nov; 44(47):15525-33. PubMed ID: 16300401
[TBL] [Abstract][Full Text] [Related]
23. Stability and crystal structures of His88 mutant human transthyretins.
Yokoyama T; Hanawa Y; Obita T; Mizuguchi M
FEBS Lett; 2017 Jul; 591(13):1862-1871. PubMed ID: 28563699
[TBL] [Abstract][Full Text] [Related]
24. Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.
Ferrão-Gonzales AD; Palmieri L; Valory M; Silva JL; Lashuel H; Kelly JW; Foguel D
J Mol Biol; 2003 May; 328(4):963-74. PubMed ID: 12729768
[TBL] [Abstract][Full Text] [Related]
25. Dynamics and Thermodynamics of Transthyretin Association from Molecular Dynamics Simulations.
Dongmo Foumthuim CJ; Corazza A; Berni R; Esposito G; Fogolari F
Biomed Res Int; 2018; 2018():7480749. PubMed ID: 29967786
[TBL] [Abstract][Full Text] [Related]
26. A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
Faria TQ; Almeida ZL; Cruz PF; Jesus CS; Castanheira P; Brito RM
Phys Chem Chem Phys; 2015 Mar; 17(11):7255-63. PubMed ID: 25694367
[TBL] [Abstract][Full Text] [Related]
27. Mispacking of the Phe87 Side Chain Reduces the Kinetic Stability of Human Transthyretin.
Sun X; Jaeger M; Kelly JW; Dyson HJ; Wright PE
Biochemistry; 2018 Dec; 57(51):6919-6922. PubMed ID: 30540442
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen-bond network and pH sensitivity in human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tanaka I; Niimura N
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):834-7. PubMed ID: 24121323
[TBL] [Abstract][Full Text] [Related]
29. Structural insight to mutated Y116S transthyretin by molecular dynamics simulation.
Banerjee A; Bairagya HR; Mukhopadhyay BP; Nandi TK; Bera AK
Indian J Biochem Biophys; 2010 Aug; 47(4):197-202. PubMed ID: 21174946
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamic stability and denaturation kinetics of a benign natural transthyretin mutant identified in a Danish kindred.
Groenning M; Campos RI; Fagerberg C; Rasmussen AA; Eriksen UH; Powers ET; Hammarström P
Amyloid; 2011 Jun; 18(2):35-46. PubMed ID: 21406045
[TBL] [Abstract][Full Text] [Related]
31. Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.
Zanotti G; Cendron L; Folli C; Florio P; Imbimbo BP; Berni R
FEBS Lett; 2013 Aug; 587(15):2325-31. PubMed ID: 23792159
[TBL] [Abstract][Full Text] [Related]
32. Quantification of quaternary structure stability in aggregation-prone proteins under physiological conditions: the transthyretin case.
Robinson LZ; Reixach N
Biochemistry; 2014 Oct; 53(41):6496-510. PubMed ID: 25245430
[TBL] [Abstract][Full Text] [Related]
33. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
Zhang Q; Kelly JW
Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.
Lim KH; Dasari AKR; Ma R; Hung I; Gan Z; Kelly JW; Fitzgerald MC
Biochemistry; 2017 Sep; 56(36):4808-4818. PubMed ID: 28820582
[TBL] [Abstract][Full Text] [Related]
35. Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers.
Lai Z; McCulloch J; Lashuel HA; Kelly JW
Biochemistry; 1997 Aug; 36(33):10230-9. PubMed ID: 9254621
[TBL] [Abstract][Full Text] [Related]
36. Hydrogen bonds connecting the N-terminal region and the DE loop stabilize the monomeric structure of transthyretin.
Inada Y; Ono Y; Okazaki K; Yamashita T; Kawaguchi T; Kawano S; Kobashigawa Y; Shinya S; Kojima C; Shuto T; Kai H; Morioka H; Sato T
J Biochem; 2023 Sep; 174(4):355-370. PubMed ID: 37400978
[TBL] [Abstract][Full Text] [Related]
37. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
[TBL] [Abstract][Full Text] [Related]
38. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.
Dasari AKR; Hung I; Gan Z; Lim KH
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):344-349. PubMed ID: 30366153
[TBL] [Abstract][Full Text] [Related]
39. A molecular mechanism for transthyretin amyloidogenesis.
Yee AW; Aldeghi M; Blakeley MP; Ostermann A; Mas PJ; Moulin M; de Sanctis D; Bowler MW; Mueller-Dieckmann C; Mitchell EP; Haertlein M; de Groot BL; Boeri Erba E; Forsyth VT
Nat Commun; 2019 Feb; 10(1):925. PubMed ID: 30804345
[TBL] [Abstract][Full Text] [Related]
40. Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity.
Redondo C; Damas AM; Saraiva MJ
Biochem J; 2000 May; 348 Pt 1(Pt 1):167-72. PubMed ID: 10794728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
